Peer Comparison
| Company | Market Price | MCAP(Cr) | P/B | P/E | EPS | ROE |
|---|---|---|---|---|---|---|
| JBCHEPHARM | 1452.8(0.0%) | 22,555 | 8.3 | 46.3 | 17.8 | 14.9 |
| GLENMARK | 795.95(0.0%) | 22,452 | 2.4 | 0.0 | 9.2 | 4.1 |
| AJANTPHARM | 1926.95(0.0%) | 24,261 | 7.0 | 36.7 | 22.6 | 17.7 |
| LAURUSLABS | 383.65(0.0%) | 20,680 | 5.1 | 56.2 | 39.8 | 45.2 |
| PEL | 918.9(0.0%) | 20,641 | 0.7 | 5.3 | 11.7 | 30.0 |
| SANOFI | 8130.2(0.0%) | 18,738 | 22.7 | 120.2 | 59.8 | 40.8 |
| PFIZER | 4080.6(0.0%) | 18,645 | 5.3 | 136.0 | 27.6 | 20.6 |
| SUVENPHAR | 665.65(0.0%) | 16,937 | 8.8 | 39.2 | 33.4 | 25.2 |
| IPCALAB | 1119.3(0.0%) | 28,422 | 4.6 | 57.7 | 11.8 | 8.9 |
| GLAXO | 1690.1(0.0%) | 28,632 | 18.6 | 44.2 | 16.5 | 5.5 |
| BIOCON | 239(0.1%) | 28,682 | 1.5 | 57.5 | 16.1 | 18.0 |
| GLAND | 1777.75(0.0%) | 29,288 | 3.5 | 41.9 | 14.0 | 10.3 |
| APLLTD | 773.6(0.7%) | 15,243 | 3.4 | 28.7 | 7.2 | 7.1 |
| NATCOPHARM | 780.25(0.0%) | 13,973 | 2.6 | 12.4 | 18.1 | 15.7 |
| ERIS | 876.35(0.0%) | 11,916 | 4.9 | 30.9 | 17.3 | 18.3 |
